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ABSTRACTSenhanced recovery programme. This process begins with appropriate case
selection, multidisciplinary team assessment, patient education, dietetic
and psychological counselling. Post-operatively it concludes with an early
return to oral intake, activity and close follow up. This study examines the
results of this efﬁciency programme with respect to length of stay (LOS)
leading to day-case (D/C) gastric bypass surgery (GBS).
Methods: A prospectively entered database was interrogated for primary
GBS performed between June 2006 and October 2012. Mean andmode LOS
were calculated.
Results: 330 patients were identiﬁed. In 2006 (n¼2) mean LOS 4.5. 2007
(n¼16) mean LOS 4.1, mode 5, 2008 (n¼31) mean LOS 2.1, mode 3, 2009
(n¼57) mean LOS 2.6, mode 2, 2010 (n¼88) mean LOS 1.8, mode 2, 2011
(n¼74)mean LOS 1.8, mode 2, 2012 (n¼62 (2¼D/C)) mean LOS 1.6, mode 1.
Conclusions:We report a decreasing length of stay evolving into day-case
gastric bypass surgery. These improvements aremultidisciplinary and day-
case rates are likely to increase.
0422: RE-INTERVENTION FOLLOWING PALLIATIVE OESOPHAGEAL
STENT INSERTION
James Douglas, Andrew Torrance, Martin Wadley. Department of Surgery,
Worcestershire Royal Hospital, Worcestershire, UK.
Introduction: Patients with advanced oesophageal cancer often present
with dysphagia. Self-expanding metal stents (SEMS) are used as a pallia-
tive therapy to relieve dysphagia and improve quality of life whilst mini-
mizing morbidity and mortality. This study aims to assess the rate and
impact of re-intervention following oesophageal stenting.
Method: A retrospective review of oesophageal stenting for malignancy
over a one year period at a single centre. Patient demographics, diagnosis,
complications, re-interventions and mortality data were collected.
Results: 58 oesophageal stents were inserted in 45 patients (30 male,
median age 79). 17 (29.3%) stents migrated. 15 (33%) patients required at
least one endoscopic re-intervention, 6 (13.3%) required a second re-
intervention and 4 (8.9%) a third. 4 (26.7%) complications were identiﬁed
in re-intervention patients compared to 1 (3.3%) complication in those
patients not requiring re-intervention (p¼0.04). 29 patients (64.4%) died
during the study period with a median survival intervention free survival
of 60 days (no-re-intervention ¼ 60 days, re-intervention ¼ 56 days).
Complications included aspiration pneumonia (3.4%), perforation (1.7%),
trachea-oesophageal ﬁstula (1.7%).
Conclusion: Oesophageal stenting with SEMS is effective with low
complication rates. One third of patients require endoscopic re-interven-
tion. Re-intervention signiﬁcantly increased the risk of complication.
0467: THE BETTER DEFINITION OF NODAL STAGING IN THE 7TH EDI-
TION OF TNM MANUAL DOES NOT PREDICT SURVIVAL OR TRANSLATES
INTO BETTER PROGNOSTICATING ABILITY IN OESOPHAGO-GASTRIC
JUNCTIONAL ADENOCARCINOMA
Ramesh Yap Kannan, Matthew Davies, Carys Jenkins, Ashraf Rasheed.
Royal Gwent Hospital, Newport, Wales, UK.
Aims: To study the impact of the 7th TNM staging on nodal neo-staging (N)
of resected and pathologically reported oesophago-gastric junctional ad-
enocarcinomas (OGJA), compare the original staging and assess possible
impact of N on overall survival (OS).
Methods: A retrospective database containing data of all consecutive
curative resections of OGJA over 10 years was obtained. Any report with
less than 12 lymph nodes was considered inadequate. All N and OS was
analysed. OS was sub-stratiﬁed into 2, 5 and 10 years post curative
resection.
Results: 57 pathology reports conﬁrming OGJA were reviewed. Adequate
lymphadenectomy (ALN) was noted in 33 patients. N was noted in 36. Of
those who had ALN (33), 20 had stagemigration. Two year survival (n¼57),
5 year survival for patients operated between 2000 to 2007 (n¼34) and 10
year survival for patients treated between 2000 to 2002 (n¼10) was
analysed. For stage 3b and stage 3c, therewas a 12.5%, 8.9% and 8.9% higher
survival rate respectively. Correspondingly for stage 1b, the survival rate
was 5.3%, 3.6% and 3.6% respectively.
Conclusion: The 7th TNMstaging better deﬁnes lymphatic staging, but does
not seem to predict survival or have a superior prognosticating ability.0488: THE EFFICACY OF ULTRASOUND SCANNING AS A DIAGNOSTIC
TOOL IN CASES OF SUSPECTED APPENDICITIS
Rishi Mandavia 1, Mimi Li 2, Hemant Sheth 3. 1North West Thames
Foundation School, London, UK; 2 Imperial College London, London, UK;
3Department of Upper Gastrointestinal Surgery, Ealing Hospital, London, UK.
Aim: Acute appendicitis continues to be a challenging diagnosis. Preop-
erative imaging using ultrasound has gained popularity as it may assist
diagnosis, particularly when clinical diagnosis is uncertain. The optimal
implementation of ultrasound has yet to be established. We aimed to
evaluate the use of ultrasound scanning in the diagnosis of appendicitis.
Method: A 1-year retrospective review of the medical records of all pa-
tients who underwent laparoscopic or open appendectomy was con-
ducted. Patient history, ultrasound reports and histological ﬁndings were
reviewed.
Results: 116 patients were included. 45 (39%) underwent ultrasonography.
The sensitivity of ultrasonography was 56.4% and speciﬁcity was 83.3%.
Accuracy of diagnosis by ultrasonography was 60.0%.
Conclusions: Ultrasonography had a high speciﬁcity, and therefore
appeared fairly accurate in excluding appendicitis. However, owing to its
poor sensitivity and accuracy rates, it did not appear particularly useful in
diagnosing appendicitis. Thus, whilst the routine use of ultrasound in all
our patients suspected of having appendicitis cannot be advocated, it may
be useful in excluding appendicitis when clinical diagnosis is uncertain.
0515: LAPAROSCOPIC SLEEVE GASTRECTOMY AND ROUTINE HISTOLOG-
ICAL EXAMINATION OF GASTRIC SPECIMENS
Jason George, Nicholas Carter, Mohamed Elkalaawy, Majid Hashemi,
Marco Adamo, Andrew Jenkinson. University College Hospital, London, UK.
Background: Laparoscopic Sleeve Gastrectomy (LSG) involves resection of
most of the stomach. Currently there are no agreements with regards to
routine histological examination of the specimen. The aim of this study
was to identify incidence of abnormalities in the specimens and to
establish if routine pathological examination is beneﬁcial.
Method: All patients who have undergone LSG during the last ﬁve years
were identiﬁed from our prospectively collected database. Histology re-
ports were retrieved. Specimens are examined macroscopically and
microscopically, noting any abnormalities, including Warthin-Starry
staining for helicobacter pylori infection (HP).
Results: During the study period, 409 gastric specimens were examined.
No dysplasia or cancer was found. 224 (54%) showed no abnormalities or
any HP infection. 1 patient had an incidental GIST completely removed. 70
(17%) had HP positivity. 63 (15%) had a degree of HP gastritis and 96 (23%)
had non HP gastritis. 2 had lymphocytic gastritis and 7 (1.7%) had benign
fundal polyps. 8 (2%) had some intestinal metaplasia.
Conclusion: 46% of gastric specimens after LSG showed abnormalities. In
addition, 17% had HP conﬁrmed, requiring post operative eradication.
Routine histological examination with HP testing of gastric specimens is
recommended after LSG.
0724: MODERN MANAGEMENT OF GASTRIC AND SMALL BOWEL GISTS
Claire Rutherford, Paul Turner. Lancashire Teaching Hospitals NHS Trust,
Lancashire, UK.
Gastrointestinal stromal tumours (GISTs) account for 1-3% of all GI ma-
lignancies. Due to their relative rarity, a retrospective case series was
performed to gain further data on current management and outcomes.
A consecutive case series was performedwithin RPH UGI Unit, assessing all
GIST resections undertaken. Patient records and MDT outcomes were
studied.
A total of 24 GIST resections were undertaken between March 2008 and
October 2012. A variety of investigations were used in the detection and
assessment of these GISTs, including CT, OGD and EUS.
All 24 resections were R0. 12 were carried out laparoscopically, 5 lapa-
roscopically-assisted and 7 open, of which the rates of laparoscopically-
assisted and open have reduced annually.
Immunohistochemistry identiﬁed 18 of the resected tumours as cKit pos-
itive and 20 as DOG1 positive. Mittenien Classiﬁcation varied from 1 to 6a.
It is essential each patient's case is discussed at a specialist UGI MDT. Due
to improved surgical techniques and equipment, patient satisfaction and
oncological outcomes are improving. Laparoscopic resection is now the
preferred technique for resectable non-malignant gastric GISTs.
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ABSTRACTSCT remains the gold standard for the detection and follow-up of these
tumours.
Although diagnosis relies on morphology and immunohistochemistry, a
proportion of GISTs are cKit negative.
0727: IS GORD REDUCED AFTER NISSEN FUNDOPLICATION IN LUNG
TRANSPLANT PATIENTS?
Victoria Pegna 1, Frans Banki 2, Ceri Rowlands 1, Antanas Mickevicius 1,
Clement Tsang 1. 1 St Vincents, Sydney, Sydney, Australia; 2Maastricht
University, Maastricht, The Netherlands.
Aims: Assess whether LungFTs improve after Nissen-Fundoplication (NF)
in lung transplant patients and if this operation reduces the use of PPIs.
Methods: Retrospective case series of transplant patients with GORD and
NF 2004-2010. The FEV1 values before and after NF were collected at 3
monthly intervals. Post NF analysis of the use of PPI, acid exposure, length
of stay and safety of this procedure, and signiﬁcance of FEV1 post-op
values was carried out using SPSS.
Results: 64 selected. The mean FEV1 declined for 6 months post opera-
tively then gradually improved. However, the median value remained
steady after having the operation then trend towards an improvement. The
two tail t-test comparing themean at 3months preoperatively to 3months
post operatively showed no signiﬁcant difference at t¼ 0.067, and at 6
months was also not signiﬁcant. All patients remained on PPIs. No
mortalities.
Conclusion: Standardisation in management between physicians and
units around the world is needed. Patients remained on PPIs post NF but
pH studies reduced in acid exposure. There was improvement in FEV1 6
months post-operatively, but not signiﬁcant. Possibly because our number
of patients was too small, or beta error. A multicenter RCT is needed to
assess this topic further.
0731: THE METABOLIC OUTCOME OF GASTRIC BYPASS SURGERY: A SYS-
TEMATIC REVIEW
Jihene El Kafsi, Rebecca Howett, Ailsa Snaith. Oxford University Hospitals,
Oxford, UK.
Recent studies show over 80% diabetes remission one year post bariatric
surgery (Buchwald 2009).
This systematic review was conducted to evaluate the evidence for
changes in glucose homeostasis and gut hormone proﬁle following Roux-
En-Y Gastric Bypass.
MEDLINE (from 1952), EMBASE (from 1980) and the Cochrane Library
were searched. Studies that reported the metabolic outcomes of patients
undergoing Roux-En-Y gastric bypass surgery were reviewed. Only those
studies with more than 10 participants in the intervention group were
considered.
From 753 retrieved abstracts, 24 studies (527 participants) were included.
Following RYGB, metabolic outcomes were reported up to 3 years post
operatively: Fasting and peak glucose levels decreased in 13 out of 16
studies. Fasting insulin levels dropped signiﬁcantly in 12 out of 13 studies.
HOMA-IR decreased signiﬁcantly. PYY levels were signiﬁcantly increased
in 9 out of 11 studies and post-prandial GLP-1 levels were signiﬁcantly
raised following RYGB in all 21 studies measuring it.
Patients who underwent RYGB have improved glucose levels and insulin
sensitivity post-operatively, regardless of diagnosis of diabetes, impaired
glucose tolerance or normal glucose control. Current NICE guidelines do
not support the use of bariatric surgery for the treatment of impaired
glucose tolerance if the BMI does not exceed 35Kg/m2.
0965: HELICOBACTER PYLORI INFECTION AND TYPE 2 DIABETES MELLI-
TUS IN BARIATRIC PATIENTS e IS THERE A LINK?
Jason George, Nicholas Carter, Sean Manning, Mohamed Elkalaawy,
Majid Hashemi, Marco Adamo, Andrew Jenkinson. University College
Hospital, London, UK.
Background: Previous reports have suggested a causal relationship be-
tween Helicobacter Pylori (HP) and type 2 Diabetes Mellitus (T2DM).
Laparoscopic Sleeve Gastrectomy (LSG) involves resection of most of the
stomach and provides ample specimen to detect the presence of any HP
organisms. The aim of this studywas to assess the relationship between HP
and T2DM in bariatric patients who have undergone LSG.Method: All patients who have undergone LSG during the last ﬁve years
were identiﬁed from our prospectively collected database. Histology re-
sults were retrieved. Specimens were examined macroscopically and any
abnormalities sampled. Warthin-Starry staining was used to identify the
presence of any Helicobacter pylori organisms.
Results: 403 gastric specimens were examined and 224 (54%) had no
abnormalities. 333 cases (83%) had no HP present and of these 32% had
T2DM. 70 cases (17%) had HP present and of these, 19 (27%) were in pa-
tients with T2DM.15% of diabetics were positive for HP compared with 19%
of non diabetics being HP positive.
Conclusion: There were comparable numbers of diabetic patients in the
HP group and the non HP group. In bariatric patients undergoing sleeve
gastrectomy, no correlationwas identiﬁed between helicobacter pylori and
type 2 diabetes mellitus.
0990: TO AUDIT THE USE OF TEMPORARY GASTRIC ELECTRICAL STIMU-
LATION IN SELECTING PATIENTS WITH INTRACTABLE GASTROPARESIS
FOR TREATMENT WITH PERMANENT GASTRIC ELECTRICAL
STIMULATION
Martin Michel 1, Simon Dexter 1, Abeezer Sarela 1, Fahmid Chowdhury 2.
1Department of Upper GI Surgery, St. James's University Hospital, Leeds, UK;
2Department of Nuclear Medicine, St. James's University Hospital, Leeds, UK.
Aims: To audit the outcomes of patients treated with Gastric Electrical
Stimulation (GES) for Intractable Gastroparesis. The largest case-series
(N¼221) reports that 54% of patients had >50% symptom reduction with
permanent Gastric Electrical Stimulation.
Methods: Patients considered for GES during 2009-2012 were identiﬁed
from a gastroparesis database. Candidates for GES had a two-week trial of
temporary stimulation (TGES), via a trans-nasal electrode that was endo-
scopically implanted into the gastric submucosa. Only those with good
response proceeded to laparoscopic implantation of the GES device. 50% or
greater in symptom-reduction was classiﬁed as a good response.
Results: There were 72 patients (51 women 71%), with a median age 44
years. The aetiology of gastroparesis was Idiopathic (43 patients,60%),
Diabetic (15 patients, 21%) or Post-surgical (14, 19%). 58 patients (80%)
underwent TGES with 47 (81%) patients having a good response and
selected to have a permanent device, which has been completed in 45
patients. 32 patients (72%) had a good response to permanent GES; these
included 20 (71%) with idiopathic, 6 (66%) with post surgical and 6 out of 7
(85%) with diabetic gastroparesis.
Conclusions: 72% of well-selected patients with intractable gastroparesis
had good response to permanent gastric electrical stimulation at follow-up
to 3 years.
1011: POOLED DAY-CASE LAPAROSCOPIC CHOLECYSTECTOMY PER-
FORMED BY BOTH UPPER GI/HPB AND GENERAL SURGEONS: A SOLU-
TION TO THE GALLSTONE EPIDEMIC?
A. Stimpson, C. Mosli-Lynch, M. Sanders, M.J. Stechman. Cardiff and Vale
University Health Board, NHS Wales, UK, Cardiff, UK.
Background: Day-case laparoscopic cholecystectomy (LC) is the optimal
treatment for most patients with symptomatic gallstones but demand is
increasing rapidly. This study examines whether an optimal service can be
provided by a combination of 6 general surgeons and 3 GI surgeons sharing
the workload.
Methods: Retrospective study of consecutive patients undergoing LC at a
day surgery unit over 2011-2012. Conversions were recorded and com-
plications graded using the Clavien-Dindo (C-D) Classiﬁcation. Statistical
analysis was by c2 test.
Results: Over 2-years 463 patients (372F, median 45y, range 16-86) un-
derwent LC. Overall, 73% had day-case surgery and conversion rate was
2.6%. Non-GI surgeons performed 315 cases (2 conversions, 10.5% C-D
grade I/II) and GI surgeons performed 148 cases (8 conversions, 6.8% C-D
grade I/II). The complication rate requiring re-intervention (ERCP/re-lap-
aroscopy, C-D grade IIIa/b) was 4% in both groups. The difference in con-
version-rate reﬂected case-mix.
Conclusions: A collaborative approach between GI-specialists and General
surgeons may be a solution to the increasing demand for LC. It can be
performed safely by both with excellent day-case rates, and low risk of
conversion or signiﬁcant complications.
